Hemovigilance is a system designed to monitor and improve the safety of blood transfusions. It involves the collection and analysis of data related to adverse events and reactions that occur during or after blood transfusions. This helps healthcare providers identify potential risks and implement measures to enhance patient safety. The primary goal of hemovigilance is to ensure that blood products, such as red blood cells and plasma, are safe for use. By tracking incidents and sharing findings, hemovigilance programs contribute to better practices in blood donation, testing, and transfusion, ultimately protecting patients and improving overall healthcare quality.